Tuesday, March 18, 2025
spot_img

BridgeBio Announces CFO Succession

PALO ALTO, Calif., March 17, 2025 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced that Thomas Trimarchi, Ph.D. has been appointed President and Chief Financial Officer (CFO) of the Company. He recently assumed the role of Principal Financial Officer and will continue to lead the Company’s FP&A and accounting operations.

Brian Stephenson, Ph.D. will depart from the Company for personal reasons. Dr. Stephenson’s departure was not the result of a disagreement with the Company on any matters relating to the Company’s operations, policies or practices. Dr. Stephenson will continue to serve as a consultant to the Company.

“It has been an immense privilege to be a part of the BridgeBio team since its inception and to help serve as many patients as possible through our efforts. I’m proud to have helped pioneer a new type of financial model – one that makes possible broad patient service through the application of portfolio theory and use of formal NPV-driven decision-making frameworks. I look forward to seeing the impact BridgeBio will continue to have on the industry and genetic disease patient communities,” said Dr. Stephenson.

About BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. (BridgeBio) is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn, Twitter and Facebook.

BridgeBio Media Contact:
Bubba Murarka, EVP Communications
[email protected]
(650)-789-8220

Powered by SlickText.com

Hot this week

Nvidia CEO Jensen Huang Announces GM Partnership: ‘The Time For Autonomous Vehicles Has Arrived’

Nvidia Corporation NVDA CEO Jensen Huang announced Tuesday a...

This Is What Whales Are Betting On Lam Research

Whales with a lot of money to spend have...

IonQ Unusual Options Activity

Deep-pocketed investors have adopted a bearish approach towards IonQ...

Michael Saylor’s Bitcoin Bet Faces Peter Schiff’s Wrath: Who’s Right About Strategy?

Strategy Inc. MSTR has been a wild ride, surging...

Topics

This Is What Whales Are Betting On Lam Research

Whales with a lot of money to spend have...

IonQ Unusual Options Activity

Deep-pocketed investors have adopted a bearish approach towards IonQ...

Intel Shares Are On The Rise Today: What’s Going On?

Intel Corporation INTC shares are trading higher Tuesday after...

Dime Announces Expansion in Manhattan With Hire of Jim LoGatto

Dime Continues to be the Bank-of-Choice for Talented BankersHAUPPAUGE,...
spot_img

Related Articles

Popular Categories

spot_img